Skip to main content

The association of serum androsterone glucuronide with inflammatory lesions in women with adult acne1


Serum androsterone glucuronide (AoG) is a metabolite of circulating androgens under the influence of 5α-reductase activity and has been shown to be particularly elevated in women with acne. In this study, we wanted to evaluate changes in AoG before and after treatment with an oral contraceptive or placebo, and to assess whether changes correlated with the number and type of acne lesions. In order to accomplish these aims, we obtained sera from a completed prospective randomized trial, which was designed to assess the effectiveness of an oral contraceptive compared to placebo. Assessments were carried out in 56 women with moderate acne who were treated with Ortho Tri-Cyclen (norgestimate and ethinylestradiol) (30 patients) or placebo (26 patients) for 6 months. Before and after treatment, the number and type of skin lesions, serum levels of total T, free-T, DHEAS and AoG were determined. Serum AoG increased significantly in women with moderate acne, although T, free-T and DHEAS were normal. 75% of acne patients had elevated levels of serum AoG. Ratios of serum AoG to androgen precursors were also elevated. Oral contraceptive (OC) treatment significantly reduced levels of free-T and AoG, both of which were unaffected by placebo. While both OC and placebo treatment resulted in improvement of comedones and inflammatory lesions, OC treatment decreased inflammatory lesions to a greater extent (p<0.05). After treatment, serum AoG correlated with the number of inflammatory lesions. Results showed that serum AoG is a sensitive marker of acne in women, even in those with normal circulating precursor androgens; and is lowered by OC treatment, correlating with the reduction of inflammatory lesions. We hypothesize that the increase of serum AoG in normoandrogenic acne may be related to inflammation, and serum AoG may serve as a marker of this process.

This is a preview of subscription content, access via your institution.


  1. 1.

    Carmina E., Lobo R.A. Hirsutism, alopecia and acne. In: Becker K.L. (Ed.), Principles and Practice of Endocrinology and Metabolism. Lippincott Co. Pub., 3rd edition, Philadelphia, 2001, p. 991.

    Google Scholar 

  2. 2.

    Lucky A.W., McGuire J., Rosenfield R.L., Lucky P.A., Rich B.H. Plasma androgens in women with acne vulgaris. J. Invest. Dermatol. 1983, 81: 70–74.

    PubMed  Article  CAS  Google Scholar 

  3. 3.

    Hammerstein J., Moltz L., Schwatz U. Antiandrogens in the treatment of acne and hirsutism. J. Steroid Biochem. 1983, 19: 591–597.

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Lemay A., Dewailly D., Grenier R., Huard J. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethinylestradiol and l-norgestrel. J. Clin. Endocrinol. Metab. 1990, 71: 8–14.

    PubMed  Article  CAS  Google Scholar 

  5. 5.

    Lookingbill D.P., Horton R., Demers L.M., Egan N., Marks J.G., Santen R.J. Tissue production of androgens in women with acne. J. Am. Acad. Dermatol. 1985, 12: 481–487.

    PubMed  Article  CAS  Google Scholar 

  6. 6.

    Thiboutot D., Harris G., Iles V., Cimis G., Gilliland K., Hagari S. Activity of the type 1 5-alpha-reductase exhibits regional differences in isolated sebaceouse glands and whole skin. J. Invest. Dermatol. 1995, 94: 279–283.

    Google Scholar 

  7. 7.

    Marynik S.P., Chakmakjian Z.H., McCaffree D.L., Herndon J.H. Androgen excess in cystic acne. N. Engl. J. Med. 1983, 308: 981–986.

    Article  Google Scholar 

  8. 8.

    Vexiau P., Husson C., Chivot M., Breault J.L. Androgen excess in women with acne alone compared with women with acne and/or hirsutism. J. Invest. Dermatol. 1990, 94: 279–283.

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Carmina E., Stanczyk F.Z., Matteri R.K., Lobo R.A. Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women. Fertil. Steril. 1991, 55: 871–876.

    Google Scholar 

  10. 10.

    Slayden S.M., Moran C., Sams W.M., Boots L.R., Azziz R. Hyperandrogenemia in patients presenting with acne. Fertil. Steril. 2001, 75: 889–892.

    PubMed  Article  CAS  Google Scholar 

  11. 11.

    Carmina E., Lobo R.A. Evidence for increased androsterone metabolism in some normoandrogenic women with acne. J. Clin. Endocrinol. Metab. 1993, 76: 1111–1114.

    PubMed  CAS  Google Scholar 

  12. 12.

    Carmina E., Gentzschein E., Stanczyk F.Z., Lobo R.A. Substrate dependency of C19 conjugates in hirsute hyperandrogenic women and the influence of adrenal androgen. Hum. Reprod. 1995, 10: 299–303.

    PubMed  CAS  Google Scholar 

  13. 13.

    Redmond G.P., Olson W.H., Lippman J.S., Kafrissen M.E., Jones T.M., Jorizzo J.L. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: A randomized, placebo-controlled trial. Obstet. Gynecol. 1997, 89: 615–622.

    PubMed  Article  CAS  Google Scholar 

  14. 14.

    Lucky A.W., Henderson T.A., Olson W.H., Robisch D.M., Lebwohl M., Swinyer L.J. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J. Am. Acad. Dermatol. 1997, 37: 746–754.

    PubMed  Article  CAS  Google Scholar 

  15. 15.

    Aydinlik S., Lachnit-Fixson U., Lehnert J. Reduced estrogen ovulation inhibitor in acne therapy: Double-blind study comparing Diane-35 to Diane. Fortschr. Med. 1986, 104: 547–550.

    PubMed  CAS  Google Scholar 

  16. 16.

    Carmina E., Ferin M., Lobo R.A. Evidence that insulin and androgens may participate in the regulation of serum leptin levels in women. Fertil. Steril. 1999, 72: 426–431.

    Article  Google Scholar 

  17. 17.

    Matteri R.K., Stanczyk F.Z., Gentzschein E.E., Delgado C., Lobo R.A. Androgen sulphate and glucuronide con- jugates in non-hirsute and hirsute women with polycystic ovary syndrome. Am. J. Obstet. Gynecol. 1989, 161: 1704–1709.

    PubMed  Article  CAS  Google Scholar 

  18. 18.

    Carmina E. A risk-benefit assessment of pharmacological therapies for hirsutism. Drug Saf. 2001, 24: 267–276.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to R. A. Lobo.

Additional information

This study was funded by Ortho-McNeil Pharmaceutical Corporation, Raritan, NJ

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Carmina, E., Godwin, A.J., Stanczyk, F.Z. et al. The association of serum androsterone glucuronide with inflammatory lesions in women with adult acne1 . J Endocrinol Invest 25, 765–768 (2002).

Download citation


  • Acne
  • androsterone glucuronide
  • hyperandrogenism